This study aimed to investigate the protective effect of oral steroid premedication in terms of adverse reactions to non-ionic contrast media. We investigated the incidence of adverse reactions among patients who underwent contrast-enhanced computed tomography. Patients in the premedication group took 30 mg of prednisolone orally the night before and on the morning of the scheduled computed tomography. Sixty-five patients received the same contrast media. Among them, 56 took prednisolone orally prior to the procedure (premedication without change of contrast media group) and nine without premedication (no premedication and no change of contrast media group). In total, 379 patients received different contrast media. Among them, 340 took prednisolone orally (premedication with change of contrast media group), while 39 did not take the premedication (no premedication with change of contrast media group). The adverse reaction rates in the premedication with change of contrast media and no premedication with change of contrast media groups were 1.8% (6/340 cases) and 2.6% (1/39 cases) (P = 0.54), respectively. The incidence of adverse reaction after the administration of non-ionic iodinated contrast media did not differ significantly based on whether an oral steroid was administered prior to compute tomography. Our evaluation is limited due to the small sample size of the contrast media-changed group. However, even if premedication with steroids is effective, it may only result in an adverse reaction reduction rate of ≤3%.
References
[1]
Katayama, H., Yamaguchi, K., Kozuka, T., Takashima, T., Seez, P. and Matsuura, K. (1990) Adverse Reactions to Ionic and Nonionic Contrast Media. A Report from the Japanese Committee on the Safety of Contrast Media. Radiology, 175, 621-628.
https://doi.org/10.1148/radiology.175.3.2343107
[2]
Wolf, G.L., Arenson, R.L. and Cross, A.P. (1989) A Prospective Trial of Ionic vs Nonionic Contrast Agents in Routine Clinical Practice: Comparison of Adverse Effects. AJR. American Journal of Roentgenology, 152, 939-944.
https://doi.org/10.2214/ajr.152.5.939
[3]
Wysowski, D.K. and Nourjah, P. (2006) Deaths Attributed to X-Ray Contrast Media on U.S. Death Certificates. AJR. American Journal of Roentgenology, 186, 613-615.
https://doi.org/10.2214/AJR.04.1790
[4]
ACR Committee on Drugs and Contrast Media (2021) ACR Manual on Contrast Media ver. https://www.acr.org/Quality-Safety/Resources/Contrast-Manual
[5]
Freed, K.S., Leder, R.A., Alexander, C., DeLong, D.M. and Kliewer, M.A. (2001) Breakthrough Adverse Reactions to Low-Osmolar Contrast Media after Steroid Premedication. American Journal of Roentgenology, 176, 1389-1392.
https://doi.org/10.2214/ajr.176.6.1761389
[6]
Wolf, G.L., Mishkin, M.M., Roux, S.G., Halpern, E.F., Gottlieb, J.A.N.I.S., Zimmerman, J., Gillen, J. and Thellman, C.H.E.R.Y.L. (1991) Comparison of the Rates of Adverse Drug Reactions. Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents. Investigative Radiology, 26, 404-410.
https://doi.org/10.1097/00004424-199105000-00003
[7]
Abe, S., Fukuda, H., Tobe, K. and Ibukuro, K. (2016) Protective Effect against Repeat Adverse Reactions to Iodinated Contrast Medium: Premedication vs. Changing the Contrast Medium. European Radiology, 26, 2148-2154.
https://doi.org/10.1007/s00330-015-4028-1
[8]
An, J., Jung, H., Kwon, O.Y., Kang, Y., Lee, J.H., Won, H.K., Song, W.J., Kwon, H.S., Cho, Y.S., Moon, H.B. and Kim, T.B. (2019) Differences in Adverse Reactions among Iodinated Contrast Media: Analysis of the KAERS Database. The Journal of Allergy and Clinical Immunology. In Practice, 7, 2205-2211.
https://doi.org/10.1016/j.jaip.2019.02.035
[9]
Lasser, E.C., Berry, C.C., Talner, L.B., Santini, L.C., Lang, E.K., Gerber, F.H. and Stolberg, H.O. (1987) Pretreatment with Corticosteroids to Alleviate Reactions to Intravenous Contrast Material. The New England Journal of Medicine, 317, 845-849.
https://doi.org/10.1056/NEJM198710013171401
[10]
Andrade, C. (2019) The P Value and Statistical Significance: Misunderstandings, Explanations, Challenges, and Alternatives. Indian Journal of Psychological Medicine, 41, 210-215. https://doi.org/10.4103/IJPSYM.IJPSYM_193_19
[11]
Faul, F., Erdfelder, E., Lang, A.G. and Buchner, A. (2007) G*Power 3: A Flexible Statistical Power Analysis Program for the Social, Behavioral, and Biomedical Sciences. Behavior Research Methods, 39, 175-191.
https://doi.org/10.3758/BF03193146
[12]
Sabharwal, S., Patel, N.K., Holloway, I. and Athanasiou, T. (2015) Sample Size Calculations in Orthopaedics Randomised Controlled Trials: Revisiting Research Practices. Acta Orthopaedica Belgica, 81, 115-122.
[13]
Freedman, K.B., Back, S. and Bernstein, J. (2001) Sample Size and Statistical Power of Randomised, Controlled Trials in Orthopaedics. The Journal of Bone and Joint Surgery. British Volume, 83, 397-402.
https://doi.org/10.1302/0301-620X.83B3.0830397
[14]
Tsushima, Y., Ishiguchi, T., Murakami, T., Hayashi, H., Hayakawa, K., Fukuda, K., Korogi, Y., Sugimoto, H., Takehara, Y., Narumi, Y., Arai, Y., Kuwatsuru, R., Yoshimitsu, K., Awai, K., Kanematsu, M. and Takagi, R. (2016) Safe Use of Iodinated and Gadolinium-Based Contrast Media in Current Practice in Japan: A Questionnaire Survey. Japanese Journal of Radiology, 34, 130-139.
https://doi.org/10.1007/s11604-015-0505-3
[15]
Mervak, B.M., Davenport, M.S., Ellis, J.H. and Cohan, R.H. (2015) Rates of Breakthrough Reactions in Inpatients at High Risk Receiving Premedication before Contrast-Enhanced CT. AJR. American Journal of Roentgenology, 205, 77-84.
https://doi.org/10.2214/AJR.14.13810
[16]
Davenport, M.S., Mervak, B.M., Ellis, J.H., Dillman, J.R., Dunnick, N.R. and Cohan, R.H. (2016) Indirect Cost and Harm Attributable to Oral 13-Hour Inpatient Corticosteroid Prophylaxis before Contrast-Enhanced CT. Radiology, 279, 492-501.
https://doi.org/10.1148/radiol.2015151143
[17]
Park, S.J., Kang, D.Y., Sohn, K.H., Yoon, S.H., Lee, W., Choi, Y.H., Cho, S.H. and Kang, H.R. (2018) Immediate Mild Reactions to CT with Iodinated Contrast Media: Strategy of Contrast Media Readministration without Corticosteroids. Radiology, 288, 710-716. https://doi.org/10.1148/radiol.2018172524
[18]
Azzouz, M., Rømsing, J. and Thomsen, H.S. (2013) Acute Non-Renal Adverse Events after Unenhanced and Enhanced Computed Tomography and Magnetic Resonance Imaging. Open Journal of Clinical Diagnostics, 3, 85-93.
https://doi.org/10.4236/ojcd.2013.33016
[19]
Davenport, M.S., Cohan, R.H., Caoili, E.M. and Ellis, J.H. (2009) Repeat Contrast Medium Reactions in Premedicated Patients: Frequency and Severity. Radiology, 253, 372-379. https://doi.org/10.1148/radiol.2532090465
